Mumbai, February 22, 2018: Pharma significant Lupin declared the dispatch of its Memantine Hydrochloride Broadened Discharge Containers, 7mg, 14mg, 21mg,28mg having gotten an endorsement from the Assembled States Sustenance and Medication Organization (FDA) prior.
Lupin’s Memantine Hydrochloride ER containers 7mg, 14mg, 21mg, 28mg are the nonexclusive counterparts of Allergan’s Namenda XR capsiles.
It is demonstrated for the treatment of direct to serious dementia of the Alzheimer’s write. Memantine Hydrochloride ER cases 7mg, 14mg, 21mg, 28mg had yearly offers of roughly USD 936 million in the US.
- This specialized division empowers patients with neurological disorders to reclaim their mobility through a…
SSI Mantra Robotic System performs a successful urology procedure on a one-year-old infant with a…
Ghaziabad, April 22, 2024: In order to strengthen the safety and wellbeing of people, Manipal Hospital…
DKMS EMPHASIZES ITS COMMITMENT TO BLOOD CANCER RESEARCH, SUPPORTS YOUNG SCIENTISTS, AND RECOGNIZES OUTSTANDING RESEARCH…
Dr. Reddy's has launched Nerivio® in Germany through its step-down subsidiary betapharm To be followed…
Hyderabad, April 13, 2024: Ankura Hospital for Women and Children is proud to announce a remarkable medical…